Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia

Blood

Volumn 93, Issue 5, 1999, Pages 1677-1683

  Rots, Marianne G ^a   Pieters, Rob ^b   Peters, Godefridus J ^b   Noordhuis, Paul ^b   Van Zantwijk, Christina H ^b   Kaspers, Gertjan J L ^b   Hählen, Karel ^b   Creutzig, Ursula ^b   Veerman, Anjo J P ^b   Jansen, Gerrit ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FOLYLPOLYGLUTAMATE SYNTHASE; GAMMA GLUTAMYL HYDROLASE; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; DRUG ACCUMULATION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033104709     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.5.1677     Document Type: Article

References (44)

1. Pui C-H: Childhood leukemias. N Engl J Med 332:1618, 1995
2. Bertino JR: Karnofsky memorial lecture. Ode to methotrexate. J Clin Oncol 11:5, 1993
3. Bender RA: Anti-folate resistance in leukemia: Treatment with "high-dose" methotrexate and citrovorum factor. Cancer Treat Rev 2:215, 1975
4. Bertino JR, Sawicki WL, Cashmore AR, Cadman EC, Skeel, RT: Natural resistance to methotrexate in human acute nonlymphocytic leukemia. Cancer Treat Rep 61:667, 1977
5. Lin JT, Tong WP, Trippett TM, Niedzwiecki D, Tao Y, Tan C, Steinherz P, Schweitzer BI, Bertino JR: Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia. Leuk Res 15:1191, 1991
6. Goker E, Kheradpour A, Waltham M, Banerjee D, Tong WP, Elisseyeff Y, Bertino JR: Acute monocytic leukemia: A myeloid leukemia subset that may be sensitive to methotrexate. Leukemia 9:274, 1995
7. Yamauchi H, Iwata N, Omine M, Maekawa T: In vitro methotrexate polyglutamate formation is elevated in acute lymphoid leukemia cells compared with acute myeloid leukemia and normal bone marrow cells. Acta Haematol Jpn 51:756, 1988
8. Chabner BA, Allegra CJ, Curt GA, Clendeninn NJ, Baram J, Koizumi S, Drake JC, Jolivet J: Polyglutamation of methotrexate. Is methotrexate a prodrug? J Clin Invest 76:907, 1985
9. Whitehead VM, Rosenblatt DS, Vuhich M-J, Shuster JJ, Witte A, Beaulieu D: Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia: A pilot prognostic factor analysis. Blood 76:44, 1990
10. Masson E, Relling MV, Synold TW, Liu Q, Schuetz JD, Sandlund JT, Pui C-H, Evans WE: Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo, a rational for high-dose methotrexate. J Clin Invest 97:73, 1996
11. Goker E, Lin JT, Trippett T, Elisseyeff Y, Tong WP, Niedzwiecki D, Tan C, Steinherz P, Schweitzer BI, Bertino JR: Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease. Leukemia 7:1000, 1993
12. Synold TW, Relling MV, Boyett JM, Rivera GK, Sandlund JT, Mahmoud H, Crist WM, Pui CH, Evans WE: Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J Clin Invest 94:1996, 1994
13. Galpin AJ, Schuetz JD, Masson E, Yanishevski Y, Synold TW, Barredo JC, Pui CH, Relling MV, Evans WE: Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: Mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity. Mol Pharmacol 52:155, 1997
14. Barredo JC, Synold TW, Laver J, Relling MV, Pui CH, Priest DG, Evans WE: Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia. Blood 84:564, 1994
15. Lenz H-J, Danenberg K, Schnieders B, Goker E, Peters GJ, Garrow T, Shane B, Bertino JR, Danenberg PV: Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction: Marked variation of expression among leukemia patients. Oncol Res 6:329, 1994
16. Longo GS, Gorlick R, Tong WP, Ercikan E, Bertino JR: Disparate affinities of antifolates for folylpolyglutamate synthetase from human leukemia cells. Blood 90:1241, 1997
17. Galivan J, Yao R, Rhee M, Schneider E, Ryan T: Glutamyl hydrolase, in Pfleider W, Rokos H (eds): Chemistry and Biology of Pteridines and Folates. Berlin, Blackwell Science, 1997, p 439
18. Li WW, Lin JT, Schweitzer BI, Tong WP, Niedwiecki D, Bertino JR: Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines. Cancer Res 52:3908, 1992
19. Li WW, Waltham M, Tong W, Schweitzer BI, Bertino JR: Increased activity of gamma-glutamyl hydrolase in human sarcoma cell lines: A novel mechanism of intrinsic resistance to methotrexate (MTX). Adv Exp Med Biol 338:635, 1993
20. Rhee MS, Wang Y, Nair MG, Galivan J: Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity. Cancer Res 53:2227, 1993
21. Pizzorno G, Moroson BA, Cashmore AR, Russello O, Mayer JR, Galivan J, Bunni M, Priest D, Beardsley GP: Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM. Cancer Res 55:566, 1995
22. Longo GS, Gorlick R, Tong WP, Lin S, Steinherz P, Bertino JR: gamma-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias. Oncol Res 9:259, 1997
23. Pieters R, Leonen AH, Huismans DR, Broekema GJ, Dirven MWJ, Heyenbrok MW, Hählen K, Veerman AJP: In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Blood 76:2327, 1990
24. Kaspers GJL, Veerman AJP, Pieters R, Broekema GJ, Huismans DR, Kazemier KM, Loonen AH, Rottier MMA, Van Zantwijk CH, Hahlen K, Van Wering ER: Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay. Br J Cancer 70:1047, 1994
25. Braakhuis BJM, Jansen G, Noordhuis P, Kegel A, Peters GJ: Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma. Biochem Pharmacol 46:2155, 1993
26. Jansen G, Kathmann I, Peters GJ, Hordijk GJ, Slootweg PJ, Van Der Laan BFAM: Activity of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in clinical specimens of head and neck tumors, in Pfleider W, Rokos H (eds): Chemistry and Biology of Pteridines and Folates. Berlin, Blackwell Scientific, 1997, p 459
27. Bradford MM: A rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein dye binding. Anal Biochem 72:248, 1976
28. O'Connor BM, Rotundo RF, Nimec Z, McGuire JJ, Galivan J: Secretion of gamma-glutamyl hydrolase in vitro. Cancer Res 51:3874, 1991
29. Waltham MC, Li WW, Gritsman H, Tong WP, Bertino JR: gamma-Glutamyl hydrolase from human sarcoma HT-1080 cells: Characterization and inhibition by glutamine antagonists. Mol Pharmacol 51:825, 1997
30. Rots MG, Pieters R, Kaspers GJL, Van Zantwijk CH, Noordhuis P, Mauritz R, Veerman AJP, Jansen G, Peters GJ: Differential methotrexate resistance in childhood T-versus common/preB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay. Blood 93:1067, 1999
31. Whitehead VM, Vuchich MJ, Lauer SJ, Mahoney D, Carroll AJ, Shuster JJ, Esseltine DW, Payment C, Look AT, Akabutu J, Bowen T, Taylor LD, Camitta B, Pullen DJ: Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (>50 chromosomes) B-lineage acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 80:1316, 1992
32. Yao R, Rhee MS, Galivan J: Effects of gamma-glutamyl hydrolase on folyl and antifolylpolyglutamates in cultured H35 hepatoma cells. Mol Pharmacol 48:505, 1995
33. Kalman TI: Mechanism-based approaches to inhibition of the synthesis and degradation of folate and antifolate polyglutamates. Adv Exp Med Biol 338:639, 1993
34. Barrueco JR, O'Leary DF, Sirotnak FM: Facilitated transport of methotrexate polyglutamates into lysosomes derived from S180 cells. J Biol Chem 267:19986, 1992
35. Barrueco JR, O'Leary DF, Sirotnak FM: Metabolic turnover of methotrexate polyglutamates in lysosomes derived from S180 cells. J Biol Chem 267:15356, 1992
36. Yao R, Schneider E, Ryan TJ, Galivan J: Human gamma-glutamyl hydrolase: Cloning and characterization of the enzyme expressed in vitro. Proc Natl Acad Sci USA 93:10134, 1996
37. Noordhuis P, Rots MG, Van Zantwijk CH, Pieters R, Veerman AJP, Peters GJ, Jansen G: Folylpolyglutamate hydrolase (FPGH) activity in human leukemia CCRF-CEM cells and blast cells from childhood leukemia patients, in Pfleider W, Rokos H (eds): Chemistry and Biology of Pteridines and Folates. Berlin, Blackwell Science, 1997, p 463
38. Goldman ID, Matherly LH: The cellular pharmacology of methotrexate. Pharmacol Ther 28:77, 1985
39. Rots MG, Noordhuis P, Willey JC, Van Zantwijk CH, DeMuth JP, Veerman AJP, Pieters R, Peters GJ, Jansen G: Expression of mRNA encoding for the reduced folate carrier and folate metabolizing enzymes in childhood leukemia cells as measured with a competitive template RT-PCR method. Annals Oncol 9:162, 1998 (abstr)
40. Gorlick R, Goker E, Trippett T, Steinherz P, Elisseyeff Y, Mazumdar M, Flintoff WF, Bertino JR: Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression. Blood 89:1013, 1997
41. Peters GJ, Jansen G: Resistance to antimetabolites, in Schilsky RL, Milano GA, Ratin MJ (eds): Principles of Antineoplastic Drug Development and Pharmacology. New York, NY, Dekker, 1996, p 543
42. Pieters R, Klumper E, Kaspers GJL, Veerman AJP: Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia. Crit Rev Oncol Hematol 25:11, 1997
43. Jansen G, Pieters R: The role of impaired transport in (pre)clinical resistance to methotrexate: Insights on new antifolates. Drug Res Updates 1:211, 1998
44. Gorlick R, Goker E, Trippett T, Waltham M, Banerjee D, Bertino JR: Intrinsic and acquired resistance to methotrexate in acute leukemia. N Engl J Med 335:1041, 1996